Share
Save
Making Football Safer for Women: Implementing an Injury Prevention Program
The aim of this study is to determine how we can best support coaches to implement an injury prevention (IP) program (Prep-to-Play) in female community Australian Football. We will recruit at least 140 female community football teams from 15 different football leagues in Victoria, Australia. Teams will be competing in U16, U17, U18, U19 or open womens competitions.
We will train and support coaches to implement the IP program and evaluate the effects of the IP program on injuries across two football seasons.
Study details:
Primary Aim: To compare the impact of supported and unsupported implementation strategies on the use of an IP program (Prep-to-Play) in female community Australian Football. Secondary aims are to:. 1.
Evaluate the effects of supported implementation of Prep-to-Play on injury risk reduction. 2. Identify barriers and enablers to sustainability of the Prep-to-Play implementation model, and develop clear recommendations for a future, sustainable national roll out of Prep-to-Play.
3. Evaluate the cost-effectiveness of Prep-to-Play. Primary hypothesis.
The primary hypothesis is that supported implementation will result in increased use of Prep-to-Play in female community Australian Football compared to unsupported implementation. Secondary hypotheses. The secondary hypotheses are that the supported implementation of Prep-to-Play will:.
* result in a reduction of anterior cruciate ligament (ACL) injuries in females participating in community Australian Football;. * result in a reduction of other musculoskeletal injuries and concussion among females participating in community Australian Football;. * be more cost-effective than the unsupported implementation.
Eligibility criteria
Researchers look for people who fit a certain description, called eligibility criteria. See if you qualify.
Inclusion criteria
Exclusion criteria
Eligibility
Age eligible for study : 14 and older
Healthy volunteers accepted : Yes
Gender eligible for study: Female
Things to know
Study dates
Study start: 2021-04-22
Primary completion: 2025-04-13
Study completion finish: 2025-12-21
Study type
PREVENTION
Phase
NA
Trial ID
NCT04856241
Intervention or treatment
OTHER: Coaching
OTHER: Peer support
OTHER: Educational materials
Conditions
- • Anterior Cruciate Ligament Injuries
- • Concussion, Brain
- • Musculoskeletal Injury
Find a site
Closest Location:
Community Australian Football Leagues
Research sites nearby
Select from list below to view details:
Community Australian Football Leagues
Melbourne, Victoria, Australia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
| Participant Group/Arm | Intervention/Treatment |
|---|---|
EXPERIMENTAL: Supported Implementation (Intervention)
| OTHER: Coaching
|
ACTIVE_COMPARATOR: Unsupported implementation (Control)
| OTHER: Educational materials
|
What is the study measuring?
Primary outcome
| Primary Outcome Measure | Primary Outcome Description | Primary Outcome Time Frame |
|---|---|---|
| Use of Prep-to-Play (Primary outcome) | Use of Prep-to-Play will be calculated as the proportion of all possible team sessions (training and games) where Prep-to-Play essential components were completed. The primary outcome assessor will be the Team Designate (i.e., nominated team manager, or team representative) who will record (via the Smartabase App or website) whether essential components of Prep-to-Play were completed at each training session and games. In addition to the Team Designate, Prep-to-Play Observers (research assistants blinded to randomisation) will make five random visits (≥one prior to the intervention period and ≥two after the intervention period) to observe the execution of Prep-to-Play in order to validate team use data from the Team Designates. | 18 months |
Secondary outcome
| Secondary Outcome Measure | Secondary Outcome Description | Secondary Outcome Time Frame |
|---|---|---|
| Number of players with an ACL injury (Secondary outcome) | The primary injuries of interest are ACL injuries and concussion. An ACL/all other injuries will be defined as any injury occurring during a football match or training that results in a player being unable to return to the field of play for that match, or missing at least one match. ACL injury definition • Ruptured ACL is confirmed by clinical examination, with or without magnetic resonance imaging or surgery. Injury data will be collected via two methods to minimise missing data: (i) sports trainer; (ii) direct from player | 18 months |
| Number of players with a concussion (Secondary outcome) | A head injury will be defined as any injury to the head region occurring during a football match or training, regardless of time loss. Concussion definition • Direct or indirect impact to the head resulting in loss of consciousness and/or any of the following clinical symptoms (memory loss, headache, dizziness, nausea, difficulty concentrating, feeling like being in a fog, feeling not quite right). Injury data will be collected via two methods to minimise missing data: (i) sports trainer; (ii) direct from player | 18 months |
| Number of player hours (training and match) | The number of training and match hours for each team will be collected, and reported at a team-level. Weekly team match exposure will be estimated from the number of matches played, multiplied by the number of players in each match (publicly available registry), and the match length (junior: 1 hour, senior: 1.5 hours). Weekly team training exposure will be estimated using the number and duration of football training sessions completed (reported by team designates), multiplied by the average number of players at training (reported by independent observers on five occasions). | 18 months |
| Healthcare utilisation | Healthcare use for players sustaining a knee or head injury will be obtained by the blinded research officer to estimate healthcare costs of sustaining an injury to inform health economic evaluation. | 18 months |
Frequently Asked Questions
Please note: some questions and answers are submitted by anonymous patients or using AI, and have not been verified by Clinrol
No questions submitted. Be the first to ask a question!